Shannon-Lowe CD - Search Results

1

SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.

Olbei M, Hautefort I, Modos D, Treveil A, Poletti M, Gul L, Shannon-Lowe CD, Korcsmaros T. Olbei M, et al. Among authors: shannon lowe cd. Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021. Front Immunol. 2021. PMID: 33732251 Free PMC article.

2

Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis.

Glover A, Zhang Z, Shannon-Lowe C. Glover A, et al. Front Immunol. 2023 Mar 23;14:1161848. doi: 10.3389/fimmu.2023.1161848. eCollection 2023. Front Immunol. 2023. PMID: 37033972 Free PMC article. Review.

3

The Global Landscape of EBV-Associated Tumors.

Shannon-Lowe C, Rickinson A. Shannon-Lowe C, et al. Front Oncol. 2019 Aug 6;9:713. doi: 10.3389/fonc.2019.00713. eCollection 2019. Front Oncol. 2019. PMID: 31448229 Free PMC article. Review.

4

The Potential for EBV Vaccines to Prevent Multiple Sclerosis.

Maple PA, Ascherio A, Cohen JI, Cutter G, Giovannoni G, Shannon-Lowe C, Tanasescu R, Gran B. Maple PA, et al. Front Neurol. 2022 Jun 24;13:887794. doi: 10.3389/fneur.2022.887794. eCollection 2022. Front Neurol. 2022. PMID: 35812097 Free PMC article.

5

Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.

Long HM, Leese AM, Chagoury OL, Connerty SR, Quarcoopome J, Quinn LL, Shannon-Lowe C, Rickinson AB. Long HM, et al. J Immunol. 2011 Jul 1;187(1):92-101. doi: 10.4049/jimmunol.1100590. Epub 2011 May 27. J Immunol. 2011. PMID: 21622860 Free PMC article.

6

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells.

Collins PJ, Fox CP, George L, Pearce H, Ryan G, De Santo C, Mussai F, Lewis D, Long H, Shannon-Lowe C. Collins PJ, et al. Blood. 2021 Jan 14;137(2):203-215. doi: 10.1182/blood.2020005611. Blood. 2021. PMID: 33443553 Free article.

7

Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth.

Shannon-Lowe C, Baldwin G, Feederle R, Bell A, Rickinson A, Delecluse HJ. Shannon-Lowe C, et al. J Gen Virol. 2005 Nov;86(Pt 11):3009-3019. doi: 10.1099/vir.0.81153-0. J Gen Virol. 2005. PMID: 16227222

8

Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.

Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W, Rickinson A, Bell A. Tierney R, et al. J Virol. 2007 Sep;81(18):10092-100. doi: 10.1128/JVI.00358-07. Epub 2007 Jul 11. J Virol. 2007. PMID: 17626071 Free PMC article.

9

Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells.

Stamataki Z, Shannon-Lowe C, Shaw J, Mutimer D, Rickinson AB, Gordon J, Adams DH, Balfe P, McKeating JA. Stamataki Z, et al. Blood. 2009 Jan 15;113(3):585-93. doi: 10.1182/blood-2008-05-158824. Epub 2008 Oct 6. Blood. 2009. PMID: 18838615 Free PMC article.

10

Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.

Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M. Shannon-Lowe C, et al. J Virol. 2009 Aug;83(15):7749-60. doi: 10.1128/JVI.00108-09. Epub 2009 May 13. J Virol. 2009. PMID: 19439479 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page